Exicure (XCUR) Total Liabilities (2016 - 2026)
Exicure's (XCUR) quarterly Total Liabilities came in at $10.7 million in Q1 2026, up 14.62% YoY from $9.3 million in Q1 2025, and up 5.36% on a QoQ basis from $10.1 million in Q4 2025.
Exicure (XCUR) Total Liabilities (2016 - 2026) Analysis & Trends
Exicure (XCUR) has 11 years of Total Liabilities data on file, last reported at $10.7 million in Q1 2026.
- Quarterly Total Liabilities rose 14.62% year-over-year to $10.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.7 million (up 14.62% YoY) and the FY2025 annual result came in at $10.1 million, up 22.1% from the prior year.
- Total Liabilities rose to $10.7 million in Q1 2026, from $10.1 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $38.7 million in Q1 2022 to a low of $7.8 million in Q2 2023.
- A 5-year average of $13.7 million and a median of $9.1 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities slumped 84.33% — and 2025, when it increased 22.1%.
- Tracing XCUR's Total Liabilities over 5 years: stood at $8.4 million in 2022, then increased by 1.7% to $8.5 million in 2023, then fell by 3.1% to $8.3 million in 2024, then increased by 22.1% to $10.1 million in 2025, then rose by 5.36% to $10.7 million in 2026.
- The last three Total Liabilities figures came in at $10.7 million (Q1 2026), $10.1 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - | 10.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.66 Mn |
| Dec 31, 2025 | 10.12 Mn |
| Sep 30, 2025 | 8.34 Mn |
| Jun 30, 2025 | 9.88 Mn |
| Mar 31, 2025 | 9.30 Mn |
| Dec 31, 2024 | 8.28 Mn |
| Sep 30, 2024 | 9.09 Mn |
| Jun 30, 2024 | 9.08 Mn |
| Mar 31, 2024 | 8.50 Mn |
| Dec 31, 2023 | 8.55 Mn |
| Sep 30, 2023 | 8.45 Mn |
| Jun 30, 2023 | 7.85 Mn |
| Mar 31, 2023 | 9.32 Mn |
| Dec 31, 2022 | 8.41 Mn |
| Sep 30, 2022 | 32.65 Mn |
| Jun 30, 2022 | 35.79 Mn |
| Mar 31, 2022 | 38.66 Mn |
| Dec 31, 2021 | 53.64 Mn |
| Sep 30, 2021 | 63.92 Mn |
| Jun 30, 2021 | 37.83 Mn |